Literature DB >> 27207978

Setting Occupational Exposure Limits for Genotoxic Substances in the Pharmaceutical Industry.

Ester Lovsin Barle1, Gian Christian Winkler2, Susanne Glowienke2, Azeddine Elhajouji2, Jana Nunic3, Hans-Joerg Martus2.   

Abstract

In the pharmaceutical industry, genotoxic drug substances are developed for life-threatening indications such as cancer. Healthy employees handle these substances during research, development, and manufacturing; therefore, safe handling of genotoxic substances is essential. When an adequate preclinical dataset is available, a risk-based decision related to exposure controls for manufacturing is made following a determination of safe health-based limits, such as an occupational exposure limit (OEL). OELs are calculated for substances based on a threshold dose-response once a threshold is identified. In this review, we present examples of genotoxic mechanisms where thresholds can be demonstrated and OELs can be calculated, including a holistic toxicity assessment. We also propose a novel approach for inhalation Threshold of Toxicological Concern (TTC) limit for genotoxic substances in cases where the database is not adequate to determine a threshold.
© The Author 2016. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  TTC; acceptable risk; genotoxicity; occupational exposure limit; threshold

Mesh:

Substances:

Year:  2016        PMID: 27207978      PMCID: PMC4914798          DOI: 10.1093/toxsci/kfw028

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  35 in total

Review 1.  Indirect mechanisms of genotoxicity.

Authors:  Micheline Kirsch-Volders; Annelies Vanhauwaert; Ursula Eichenlaub-Ritter; Ilse Decordier
Journal:  Toxicol Lett       Date:  2003-04-11       Impact factor: 4.372

2.  Scientific and practical considerations for the development of occupational exposure limits (OELs) for chemical substances.

Authors:  D M Galer; H W Leung; R G Sussman; R J Trzos
Journal:  Regul Toxicol Pharmacol       Date:  1992-06       Impact factor: 3.271

3.  [Evaluation of the genotoxicity of vincristine and colchicine using mouse lymphoma tk mutation assay].

Authors:  Yi-jing Wang; Li-shi Zhang
Journal:  Wei Sheng Yan Jiu       Date:  2006-03

Review 4.  Assessment of mechanisms driving non-linear dose-response relationships in genotoxicity testing.

Authors:  M Guérard; M Baum; A Bitsch; G Eisenbrand; A Elhajouji; B Epe; M Habermeyer; B Kaina; H J Martus; S Pfuhler; C Schmitz; A Sutter; A D Thomas; C Ziemann; R Froetschl
Journal:  Mutat Res Rev Mutat Res       Date:  2014-11-11       Impact factor: 5.657

5.  Guidance on the establishment of acceptable daily exposure limits (ADE) to support Risk-Based Manufacture of Pharmaceutical Products.

Authors:  Edward V Sargent; Ellen Faria; Thomas Pfister; Robert G Sussman
Journal:  Regul Toxicol Pharmacol       Date:  2013-01-03       Impact factor: 3.271

Review 6.  Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs).

Authors:  Joel P Bercu; Eric J Morinello; Claudia Sehner; Bryan K Shipp; Patricia A Weideman
Journal:  Regul Toxicol Pharmacol       Date:  2016-05-24       Impact factor: 3.271

7.  Permissible levels for occupational exposure; basic concepts.

Authors:  R L Zielhuis; W R Notten
Journal:  Int Arch Occup Environ Health       Date:  1979-01-15       Impact factor: 3.015

8.  Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.

Authors:  Lutz Müller; Elmar Gocke; Thierry Lavé; Thomas Pfister
Journal:  Toxicol Lett       Date:  2009-04-10       Impact factor: 4.372

9.  Dose translation from animal to human studies revisited.

Authors:  Shannon Reagan-Shaw; Minakshi Nihal; Nihal Ahmad
Journal:  FASEB J       Date:  2007-10-17       Impact factor: 5.191

Review 10.  Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals.

Authors:  John F Reichard; M Andrew Maier; Bruce D Naumann; Alison M Pecquet; Thomas Pfister; Reena Sandhu; Edward V Sargent; Anthony J Streeter; Patricia A Weideman
Journal:  Regul Toxicol Pharmacol       Date:  2016-05-22       Impact factor: 3.271

View more
  1 in total

1.  A simple approach to assess the cancer risk of occupational exposure to genotoxic drugs in healthcare settings.

Authors:  Johannes Gerding; Lea Anhäuser; Udo Eickmann; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2022-04-01       Impact factor: 2.646

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.